Financial Performance - The company's total revenue for the first nine months of 2023 was ¥340,503,288.11, a decrease of 18.69% compared to ¥418,760,352.43 in the same period last year[9] - The net profit attributable to shareholders for the first nine months of 2023 was ¥17,463,367.10, down 64.76% from ¥49,550,014.50 in the previous year[9] - The net cash flow from operating activities for the first nine months of 2023 was -¥9,208,418.10, a decline of 105.22% compared to ¥176,412,122.33 in the same period last year[9] - In Q3 2023, the company reported a revenue of ¥125,824,509.70, an increase of 11.18% from ¥113,167,578.67 in Q3 2022[9] - The net profit attributable to shareholders in Q3 2023 was ¥10,930,318.04, a significant increase of 165.74% compared to ¥4,113,149.09 in Q3 2022[9] - Total operating revenue for the first nine months of 2023 was ¥340,503,288.11, a decrease of 18.7% compared to ¥418,760,352.43 in the same period of 2022[36] - Net profit for the first nine months of 2023 was ¥19,268,940.54, a decline of 76.1% from ¥80,863,532.38 in 2022[37] - The net profit for the first nine months of 2023 was CNY 16,153,778.52, a decrease compared to CNY 61,346,478.45 in the same period of 2022, reflecting a decline of approximately 73.7%[41] - The total comprehensive income for the first nine months of 2023 was CNY 16,222,337.48, significantly lower than CNY 61,682,959.78 in the same period of 2022, marking a decline of approximately 73.8%[41] Assets and Liabilities - The total assets as of September 30, 2023, were ¥904,774,023.81, reflecting a 7.31% increase from ¥843,106,834.73 at the end of 2022[10] - The company's net assets attributable to shareholders increased by 28.68% to ¥553,041,049.54 from ¥429,763,900.32 at the end of the previous year[10] - Assets with restricted rights amount to ¥166,257,329.84, representing 18.38% of total assets, primarily due to bank loans and guarantees[24] - Total liabilities decreased to ¥243.17 billion from ¥307.04 billion, a reduction of about 20.8%[30] - Current liabilities totaled ¥213.07 billion, down from ¥255.19 billion, indicating a decrease of approximately 16.5%[29] - Total liabilities decreased to ¥29,787,556.38 in 2023 from ¥32,463,203.52 in 2022, reflecting a reduction of 8.3%[34] Cash Flow - Operating cash flow for the first nine months of 2023 was negative at CNY -9,208,418.10, contrasting with a positive cash flow of CNY 176,412,122.33 in the same period of 2022[42] - Cash flow from investing activities showed a net outflow of CNY -99,096,689.95, slightly improved from CNY -104,126,414.34 in the previous year[43] - Net cash flow from investment activities was -$82.33 million, a decrease from $44.69 million in the previous period[46] - Net cash flow from financing activities was $110.33 million, a significant improvement from -$25.72 million in the previous period[46] Shareholder Information - The total number of ordinary shares is 83,200,000, with 31.18% being unrestricted shares and 68.82% being restricted shares[16] - The largest shareholder, Gao Wengao, holds 27.67% of the shares, while the top ten shareholders collectively own 67.26%[17] - There are no pledges or judicial freezes on shares held by shareholders with more than 5% ownership[19] Investments and Expenses - The company raised ¥141,768,000.00 through the public issuance of 13.2 million shares, with a net amount of ¥121,525,434.00 after deducting issuance costs[12] - The company reported a significant increase of 1,215.71% in construction in progress, amounting to ¥75,890,498.40, due to ongoing investment projects[11] - Research and development expenses for the first nine months of 2023 were ¥14,605,859.97, down 23.6% from ¥19,158,068.62 in 2022[37] - The company reported a decrease in financial expenses to ¥625,594.47 in 2023 from ¥1,577,816.82 in 2022, a reduction of 60.3%[37] Other Income and Expenses - Non-operating income totaled ¥8,327,891.22, with a net non-operating income of ¥5,798,812.72 after tax effects[14] - The company received government subsidies amounting to ¥7,359,779.44, which are closely related to its normal business operations[14] - The company reported a loss of ¥71,550.00 from the disposal of non-current assets[14] - Other income increased to ¥7,553,367.93 in 2023 from ¥4,357,987.95 in 2022, marking a growth of 73.5%[37]

证券代码：832471 证券简称：美邦科技 公告编号：2023-089 河北美邦工程科技股份有限公司 关于收到北京证券交易所 2023 年半年报问询函的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 （2）结合业务开展情况说明解决方案营业收入及毛利率大幅增长的原因及 合理性； （3）补充说明境外业务涉及的主要国家、对应销售的产品及销售规模、主 要客户及销售额、收入确认方式、结算政策、应收账款余额及回款情况，并结合 国内外业务差异等，说明境内外收入反向变动的原因及合理性。 2、关于存货 河北美邦工程科技股份有限公司（以下简称"公司"）于 2023 年 9 月 28 日 收到北京证券交易所上市公司管理部下发的《关于对河北美邦工程科技股份有 限公司的半年报问询函》（半年报问询函【2023】第 007 号）（以下简称"《问 询函》"），现将《问询函》内容公告如下： 河北美邦工程科技股份有限公司（美邦科技）董事会： 我部在上市公司 2023 年半年度报告事后审查中关注到以下情况： 1、关于经营情况 报告期内 ...

关于对河北美邦工程科技股份有限公司的 半年报问询函 半年报问询函【2023】第 007 号 河北美邦工程科技股份有限公司（美邦科技）董事会： 我部在上市公司 2023 年半年度报告事后审查中关注到以下情况： 1、关于经营情况 按产品类别看，精细化工产品实现营业收入 1.95 亿元，同比下 降 34.6%，毛利率 12.91%，较上年同期减少 25 个百分点；解决方案 实现营业收入 1,975.74 万元，同比增长 236.2%，毛利率 42.32%，较 上年同期增加 11.9 个百分点。按销售区域看，境内实现营业收入 1.97 亿元，同比下降 33.52%，毛利率 16.98%，较上年同期减少 21.44 个 百分点；境外实现营业收入 1,770.21 万元，同比增长 90.32%，毛利 率 0.43%，较上年同期减少 12.1 个百分点。 请你公司： （1）说明报告期主营业务开展情况、收入下滑的具体原因；结 合行业情况、公司经营模式、产品价格变动、收入构成及成本变化、 产能利用率、期间费用等情况，分析说明净利润大幅下滑且明显超过 营业收入下降幅度的具体原因，与同行业可比公司是否存在较大差异， 下滑趋势是否将 ...

本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 河北美邦工程科技股份有限公司 2023 年半年度权益分派方案已获 2023 年 9 月 6 日召开的股东大会审议通过，现将权益分派事宜公告如下： 本次权益分派基准日合并报表归属于母公司的未分配利润为 212,478,889.06 元，母公司未分配利润为 182,296,896.17 元。本次权益分派共计派发现金红利 16,640,000.00 元。 一、权益分派方案 1、本公司 2023 年半年度权益分派方案为： 证券代码：832471 证券简称：美邦科技 公告编号：2023-088 河北美邦工程科技股份有限公司 2023 年半年度权益分派实施公告 本次分派对象为：截止 2023 年 9 月 19 日下午北京证券交易所收市后，在中 国证券登记结算有限责任公司北京分公司（以下简称"中国结算北京分公司"） 登记在册的本公司全体股东。投资者 R 日（R 日为权益登记日）买入的证券，享 有相关权益；对于投资者 R 日卖出的证券，不享有相关权益。 四、权益分派方法 ...

证券代码：832471 证券简称：美邦科技 公告编号：2023-087 河北美邦工程科技股份有限公司 （二） 本次增持计划主要内容 本次增持计划具体内容详见本公司于 2023 年 6 月 7 日披露的《河北美邦工 程科技股份有限公司关于实施稳定股价方案的公告》（公告编号：2023-064）。 （三） 增持措施实施结果 公司于 2023 年 6 月 7 日披露《关于实施稳定股价方案的公告》，于 6 月 8 日开始实施，并于 2023 年 9 月 8 日已实施完毕，具体增持情况如下： | | | | 增 | | | | | 增 持 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 增持 | 增持 | | | | 增持价 | | | 当前持股 | 当前持 | | 股东名 | 数量 | 比例 | 持 | 增持 | | 格区间 | 增持总金 | 完 | 数量 | 股比例 | | 称 | （股） | （%） | 方 | 期间 | | （元） | 额（元） | 成 | （股） | （%） | | | | | 式 | | ...

法律意见书 北京市中伦律师事务所 关于河北美邦工程科技股份有限公司 2023 年第五次临时股东大会的 法律意见书 致：河北美邦工程科技股份有限公司 为出具本法律意见书，本所律师审查了公司本次股东大会的有关文件和材 料。本所律师得到公司如下保证，即其已提供了本所律师认为出具本法律意见书 所必需的材料，所提供的原始材料、副本、复印件等材料、口头证言均符合真实、 准确、完整的要求，有关副本、复印件等材料与原始材料一致。 在本法律意见书中，本所律师对本次股东大会的召集、召开程序、出席会议 法律意见书 北京市中伦律师事务所（以下简称"本所"）接受河北美邦工程科技股份有 限公司（以下简称"公司"）的委托，指派本所律师对公司 2023 年第五次临时 股东大会（以下简称"本次股东大会"）的相关事项进行见证并出具法律意见书。 本所及本所律师依据《中华人民共和国证券法》（以下简称"《证券法》"）、 《律师事务所从事证券法律业务管理办法》和《律师事务所证券法律业务执业规 则（试行）》等规定及本法律意见书出具日以前已经发生或者存在的事实，严格 履行了法定职责，遵循了勤勉尽责和诚实信用原则，进行了充分的核查验证，保 证本法律意见书所认 ...

证券代码：832471 证券简称：美邦科技 公告编号：2023-086 河北美邦工程科技股份有限公司 2023 年第五次临时股东大会决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2023 年 9 月 6 日 2.会议召开地点：公司会议室 3.会议召开方式：现场与网络投票相结合的方式 4.会议召集人：公司董事会 5.会议主持人：董事长高文杲先生 6.召开情况合法、合规、合章程性说明： 本次会议的召开、召集和表决程序符合《公司法》和《公司章程》有关 法律法规以及公司内部治理规则的规定，所作决议合法有效。 2.公司在任监事 3 人，出席 3 人； 3.公司董事会秘书出席会议； 4. 公司部分高级管理人员列席会议。 二、议案审议情况 （一）审议通过《关于公司 2023 年半年度权益分派预案的议案》 1.议案内容： （二）会议出席情况 出席和授权出席本次股东大会的股东共 12 人，持有表决权的股份总数 54,887,160 股，占公司有表决 ...

证券代码：832471 证券简称：美邦科技 公告编号：2023-085 河北美邦工程科技股份有限公司 投资者关系活动记录表 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、投资者关系活动类别 □特定对象调研 √业绩说明会 □媒体采访 □现场参观 □新闻发布会 □分析师会议 □路演活动 □其他（请文字说明其他活动内容） 二、投资者关系活动情况 （一）活动时间、地点 河北美邦工程科技股份有限公司(以下简称"公司")于 2023 年 8 月 28 日 （星期 一 ） 15:00-16:30 通过全景网 " 投 资 者 关 系 互 动 平 台 " （https://ir.p5w.net）采用网络方式召开 2023 年半年度报告业绩说明会。 （二）参与单位及人员 通过网络方式参加公司 2023 年半年度报告业绩说明会的投资者。 （三）上市公司接待人员 公司董事长、总经理：高文杲先生 公司董事、副总经理：张利岗先生 公司董事、副总经理、董事会秘书：王晓丽女士 公司财务负责人：聂燕女士 公司保荐代表人：王吉祥先生 ...

证券代码：832471 证券简称：美邦科技 公告编号：2023-084 河北美邦工程科技股份有限公司 2023 年半年度报告业绩说明会预告公告 本次业绩说明会将采用网络方式召开，投资者可登陆全景网"投资者关系 互动平台"（https://ir.p5w.net）参与本次业绩说明会。 三、 参加人员 公司董事长、总经理：高文杲先生 公司董事、副总经理：张利岗先生 公司董事、副总经理、董事会秘书：王晓丽女士 公司财务负责人：聂燕女士 公司保荐代表人：王吉祥先生 四、 投资者参加方式 本次说明会采用网络方式召开。 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 一、 说明会类型 河北美邦工程科技股份有限公司（以下简称"公司"）于 2023 年 8 月 21 日在北京证券交易所官方信息披露平台（www.bse.cn）披露了《河北美邦工程 科技股份有限公司 2023 年半年度报告》（公告编号：2023-079）及《河北美邦 工程科技股份有限公司 2023 年半年度报告摘要》（公告编号：2023-080），为 方便广 ...

Innovation and Patents - The company applied for 5 national patents during the reporting period, including 3 invention patents and 2 utility model patents, and was granted 9 national patents, comprising 5 invention patents and 4 utility model patents[11]. - The company has a total of 155 authorized patents, including 64 invention patents, enhancing its technological capabilities in green manufacturing[39]. - The company has 187 national patents filed, with 155 patents granted, including 64 invention patents and 91 utility model patents[67]. - The company has made significant advancements in research and development, evidenced by the award received for its invention patent related to benzaldehyde preparation[7]. Financial Performance - The company's operating revenue for the current period is CNY 214,678,778.41, a decrease of 29.75% compared to the same period last year[32]. - The net profit attributable to shareholders of the listed company is CNY 6,533,049.06, down 85.62% year-on-year[32]. - The gross profit margin fell to 15.62%, down from 37.63% in the previous year, indicating a substantial decline in profitability[49]. - The company reported a net profit of CNY 8,004,242.37, a decrease of 89.20% compared to the previous year, primarily due to a significant drop in tetrahydrofuran prices[51]. - Operating revenue decreased by 29.75% to CNY 214,678,778.41 compared to the previous year, with a significant drop in operating profit by 89.88% to CNY 8,194,922.34[49][51]. Market and Business Development - The company is actively expanding its market presence and technological capabilities through strategic initiatives and partnerships[25]. - The company plans to enhance market expansion and strategic partnerships to mitigate risks associated with market fluctuations and industry cycles[66]. - The company’s focus on green technology aligns with current market trends towards sustainability in the chemical industry[25]. - The company is committed to providing green manufacturing solutions in the fields of new chemical materials and biomedicine[144]. Capital and Shareholder Information - The company successfully listed on the Beijing Stock Exchange on May 25, 2023, with a total share capital of 83,200,000 shares[10][25]. - The company's registered capital is 83,200,000 yuan, reflecting its financial stability and growth potential[27]. - The total number of ordinary shares increased from 70,000,000 to 83,200,000 due to a public offering of 13,200,000 shares on May 25, 2023[83]. - The top ten shareholders collectively hold 67.16% of the shares, with the largest shareholder owning 27.67%[86]. Cash Flow and Liquidity - The net cash flow from operating activities is negative at CNY -11,140,152.82, a decline of 106.48% compared to the previous year[33]. - Cash and cash equivalents increased by 34.93% to CNY 221,502,315.78, primarily due to the public issuance of 13.2 million shares, raising a net amount of CNY 121,525,434.00 after deducting issuance costs[48]. - Net cash flow from financing activities surged by 416.02% to ¥119,582,206.52, an increase of ¥157,422,047.50, primarily due to the public issuance of 13.2 million shares, raising a net amount of ¥121,525,434.00 after deducting issuance costs[60]. Assets and Liabilities - The total assets at the end of the period amount to CNY 930,017,213.37, reflecting a growth rate of 10.31%[33]. - The total liabilities decreased by 14.39% to CNY 262,858,052.97, resulting in an asset-liability ratio of 28.26%[33]. - The total current assets of the company as of June 30, 2023, were CNY 511,255,016.57, an increase from CNY 448,887,570.07 at the end of 2022, reflecting a growth of approximately 13.8%[105]. - The total liabilities decreased to ¥262,858,052.97 from ¥307,037,554.75, indicating a decline of around 14.3%[107]. Research and Development - The company is focusing on green chemical technology as a key development direction to enhance resource and energy utilization efficiency while reducing pollution[46]. - Research and development expenses for the first half of 2023 were ¥9,759,378.36, a decrease of 17.5% from ¥11,844,700.31 in the same period of 2022[114]. - The company aims to maintain its technological leadership by increasing R&D investment in advanced green manufacturing technologies[67]. Corporate Governance and Social Responsibility - The company emphasizes social responsibility and sustainable value creation through technological innovation and green process engineering[65]. - The company has established a comprehensive human resource management system to prevent the loss of core personnel and attract talent[68]. - The company has not experienced significant changes in major risks during the reporting period[68]. - The company has no instances of shareholder or related party misappropriation of funds, assets, or other resources during the reporting period[76]. Dividend and Profit Distribution - The company plans to distribute a cash dividend of ¥2.00 per 10 shares, with no stock bonuses or capital increases proposed[94]. - The company reported a total comprehensive income for the first half of 2023 of ¥8,087,814.46, which includes a net profit distribution of ¥6,533,049.06[127]. Accounting Policies and Financial Reporting - The company’s financial reports comply with the requirements of the accounting standards and reflect its financial position as of June 30, 2023[150]. - The company has not reported any changes in accounting policies or prior period error corrections for the current period[126]. - The company’s accounting policies are based on the accrual basis of accounting, with historical cost as the measurement basis for most financial statements[148].